Florida Atlantic University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Florida Atlantic University sits in the top decile of US sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count).

27 total trials 5 currently recruiting 13 completed top decile by trial count

Florida Atlantic University: 27 sponsored US clinical trials, 5 recruiting.

Florida Atlantic University sponsors 27 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 13 completed. 5 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Unnecessary Hospitalizations of Nursing Home Residents, with 1 trials.

Top-decile sponsor footprint

Florida Atlantic University ranks in the top decile of sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 0/100

13 of 22 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (59.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

27 total, page 1 of 1

RECRUITING NA

Impact of Dog Adoption and Training in Veterans With Post-traumatic Stress Symptoms and/or Other Mental Health Conditions

NCT07542431

RECRUITING NA

Exploring the Feasibility of an Exercise and Noninvasive Brain Stimulation Intervention in Breast Cancer Survivors

NCT07587957

RECRUITING NA

The Geriatric Emergency Department Pharmacologic Harm Prevention Project

NCT07216846

RECRUITING

Brain NAD in Alzheimer's Disease

NCT07127510

RECRUITING Phase 3

Lidocaine Versus Diphenhydramine to Achieve Local Anesthesia for Laceration Repairs

NCT06910241

COMPLETED NA

Geriatric Emergency Department Fall Injury Prevention Project

NCT05807724

COMPLETED NA

Optimizing Rural Community Health Through Dementia Detection and Care

NCT05760521

COMPLETED NA

Evaluating a Travel App's Influence on College Student Commuting to Campus

NCT04720300

COMPLETED

Geriatric Head Trauma Short Term Outcomes Project

NCT04044924

COMPLETED NA

Improving Diet Protein Intake in Middle-aged Women

NCT04660851

COMPLETED NA

Improving Dietary Protein Intake in Adults

NCT04378556

COMPLETED NA

Virtual Neuroprosthesis: Restoring a Sense of Touch to Amputees

NCT03581448

TERMINATED NA

Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

NCT02717130

COMPLETED NA

Effect of Chair Yoga on Elders With Osteoarthritis

NCT02113410

COMPLETED NA

Involving Nursing Home Residents and Their Families in Acute Care Transfer Decisions

NCT02568475

COMPLETED NA

Reducing Hospitalizations of Nursing Home Residents

NCT02177058

COMPLETED Phase 4

Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease

NCT00476008

TERMINATED Phase 3

Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes

NCT01029444

TERMINATED Phase 2

Effects of Pulsatile Intravenous Insulin Therapy on Metabolic Integrity in Patients With Diabetes Mellitus

NCT00539409

COMPLETED Phase 4

Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome

NCT00272311

COMPLETED Phase 4

Aspirin Dose and Atherosclerosis in Patients With Heart Disease

NCT00272337

TERMINATED Phase 2

Effects of Pulsatile Intravenous (IV) Insulin on Wound Healing in Diabetics

NCT00967837

TERMINATED Phase 2

Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes Mellitus

NCT00287651

TERMINATED Phase 2

Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes

NCT00361907

TERMINATED Phase 2

Effects of Pulsatile Insulin Delivery on Diabetic Neuropathy in Patients With Types 1 and 2 Diabetes Mellitus

NCT00228891

TERMINATED Phase 2

Clinical Effects of Pulsatile Insulin Delivery on Cognitive Function- Phase 1

NCT00228865

TERMINATED Phase 2

Effect Pulsatile IV Insulin Therapy on the Quality of Life in Patients With Types 1 and 2 Diabetes

NCT00228878

What is open in the Florida Atlantic University pipeline

5 recruiting of 27 indexed (19% open); 13 completed (48%).

Phase mix: 5 late (III/IV) vs 7 early (I/II) (balanced across stages).

Top condition: Unnecessary Hospitalizations of Nursing Home Residents (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Florida Atlantic University: open-pipeline peers nationwide

Peers matched on 27 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Florida Atlantic University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400 0%5%10%15%20% Total trials Recruiting share Florida Atlantic UniversityAkron Children's HospitalArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)AVEO PharmaceuticalsDompé Farmaceutici S.p.AInstitut de Recherches Internationales ServierNateraNemours Children's ClinicThomas Jefferson University
Florida Atlantic University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Florida Atlantic University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 27 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Florida Atlantic University page

27 registered trials is a research-attention snapshot, not an endorsement of Florida Atlantic University or any single study.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Florida Atlantic University pipeline card: 27 registered trials from official public datasets.Report a data error.